European Investment Bank — Press releases·SE·
Swedish health-tech company Elekta to advance cancer treatments with €100 million EIB loan
The European Investment Bank (EIB) is lending up to €100 million to Swedish medical-technology company Elekta AB to advance treatments for a range of cancers and neurological diseases. The EIB loan will support Elekta’s research and development work in radiotherapy, radiosurgery, brachytherapy and the software used to plan and deliver therapies.
Read releases like this the second they cross the wire.
1,100+ feeds from 80+ newswires in one live cockpit — saved searches, instant alerts, AI summaries. 7-day free trial, no card required.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live on PPN World.
PPN Source →Shared via PPN World — real-time press release intelligence.